Long‑Term Implementation and Effectiveness of a Quality Improvement Intervention for Myocardial Infarction in Tanzania
View Full Paper
Ask AI
Bookmark
Share
Key result
MIMIC quality improvement intervention linked to sustained increase in 30-day antiplatelet use from 10% to 52%.
- OR 9.54
- 95% CI 2.49-46.46
- P<0.001
- n=837
Why the study?
Whether the Multicomponent Intervention to Improve Myocardial Infarction Care in Tanzania (MIMIC) was sustained as implemented and its clinical gains persisted after its initial pilot trial was unknown.
Does a multicomponent quality improvement intervention (MIMIC) sustain improved AMI care metrics one year post-implementation in a resource-limited Tanzanian emergency department?
Population
Adults with chest pain or dyspnea in a Tanzanian ED, including 260 post-pilot participants
Comparison
Post-pilot period vs pilot period and pre-intervention baseline
Design
Sequential cohort study
Follow-up
One year
Authors
Discussion
Loading...
Member takes
Implication
Sustained AMI care gains one year post-pilot support pragmatic ED interventions in low-resource settings; leaves open broader adoption and mortality effects.
Study Design
Type
Cohort (n=837)
Multicenter
No
Structured PICO
Does a multicomponent quality improvement intervention (MIMIC) sustain improved AMI care metrics one year post-implementation in a resource-limited Tanzanian emergency department?
P
Population
837 adults presenting with chest pain or dyspnea to a Tanzanian emergency department, evaluated for acute myocardial infarction over a pilot and 1-year post-pilot period.
I
Intervention
Multicomponent Intervention to Improve Myocardial Infarction Care (MIMIC) evaluated during a 12-month post-pilot period. Components include triage cards, pocket reference cards, web-based training, patient education, and clinical champions.
C
Comparator
Pilot trial period (12 months) and pre-pilot baseline period (7 months) receiving usual care or initial implementation.
O
Outcome
Fidelity and penetration of MIMIC components and 11 AMI care metrics (including ECG completion, cardiac biomarker testing, evidence-based therapies, and 30-day survival).
Main Result
Odds Ratio: 9.54 (95% CI 2.49–46.46)
Absolute Event Rate: 52% vs 10%
p-value: p=<0.001
A pragmatic, workflow-integrated quality improvement intervention for AMI care in a resource-limited Tanzanian emergency department demonstrated sustained fidelity and clinical effectiveness one year post-implementation.
Limitations
- Single-site study, which may limit generalizability
- Differences in sample sizes across comparison periods may have reduced statistical precision
- Reduced research assistant coverage during the post-pilot period may have introduced selection bias
- Pre-post analysis may be influenced by unmeasured temporal trends
- Recurrent stock-outs of cardiac biomarker reagents limited completeness of biomarker assessment and may have contributed to underdiagnosis of NSTEMI
- Direct observation may have introduced Hawthorne effects
- Patient self-report may be subject to recall or social-desirability bias
- Small post-pilot AMI sample size (n=29) limiting inferential power
- Periodic stock-outs of cardiac biomarker assay reagents
- Different screening and enrollment hours between study periods due to budget constraints
Cite This Study
Wang et al. (2026) conducted a cohort in Acute myocardial infarction (n=837). Multicomponent Intervention to Improve Myocardial Infarction Care (MIMIC) vs. Pre-intervention baseline was evaluated on 30-day antiplatelet use (OR 9.54, 95% CI 2.49-46.46, p=<0.001). One year after implementation, the MIMIC quality improvement intervention demonstrated sustained clinical effectiveness, including a significant increase in 30-day antiplatelet use compared to pre-intervention baseline (52% vs 10%, OR 9.54).
Topics
View Full Paper
Ask AI
Bookmark
Share